Accustem Sciences Inc Asset Turnover Ratio (ACUT), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Accustem Sciences Inc   (ACUT)
 

Accustem Sciences Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Accustem Sciences Inc asset turnover ratio, the ability of Accustem Sciences Inc 's assets to generate revenue in the second quarter 2026, increased sequentially to 0.06 in the second quarter (Jun 30 2026), ACUT's balance sheet remain strong.

Within sector Accustem Sciences Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Second Quarter 2026 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ACUT Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change -0.46 % -0.07 % 2945.15 % 1415.42 % 1055.14 %
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) 0.06 - - - -
ACUT's Total Ranking # # # # #
Seq. Asset Change 3.66 % 0 % -1.51 % -2.5 % 4.06 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 




ACUT Company Profile • Back to ACUT Efficiency Comparisons • Compare ACUT Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Coherus Oncology inc   0.17 $ 50.936  Millions$ 308.017  Millions
Prelude Therapeutics Inc  0.16 $ 22.424  Millions$ 136.269  Millions
Prothena Corporation Public Limited Company  0.16 $ 54.530  Millions$ 332.976  Millions
Opus Genetics Inc   0.16 $ 9.856  Millions$ 61.530  Millions
Skinvisible Inc   0.16 $ 0.020  Millions$ 0.126  Millions
Maxcyte inc   0.16 $ 31.051  Millions$ 198.782  Millions
Abeona Therapeutics Inc   0.15 $ 30.093  Millions$ 207.166  Millions
Voyager Therapeutics Inc   0.14 $ 34.459  Millions$ 239.417  Millions
Standard Biotools Inc   0.14 $ 83.691  Millions$ 593.430  Millions
Femasys Inc   0.14 $ 2.299  Millions$ 16.450  Millions
Seastar Medical Holding Corp  0.14 $ 1.713  Millions$ 12.400  Millions
Sintx Technologies Inc   0.14 $ 1.330  Millions$ 9.778  Millions
Xencor Inc  0.13 $ 104.973  Millions$ 801.528  Millions
Lucid Diagnostics Inc   0.13 $ 5.445  Millions$ 41.667  Millions
Royalty Pharma Plc  0.13 $ 2,535.998  Millions$ 19,650.812  Millions
Omniab Inc   0.13 $ 38.457  Millions$ 298.628  Millions
Lineage Cell Therapeutics Inc   0.13 $ 13.083  Millions$ 104.494  Millions
Igc Pharma Inc   0.12 $ 1.101  Millions$ 9.293  Millions
Kura Oncology Inc   0.12 $ 77.225  Millions$ 657.022  Millions
Arcus Biosciences Inc   0.12 $ 117.000  Millions$ 1,008.500  Millions
Arcturus Therapeutics Holdings Inc   0.11 $ 29.368  Millions$ 255.803  Millions
China Pharma Holdings Inc  0.11 $ 3.914  Millions$ 34.164  Millions
Pmgc Holdings Inc   0.11 $ 2.579  Millions$ 22.601  Millions
Tonix Pharmaceuticals Holding Corp   0.11 $ 29.102  Millions$ 260.403  Millions
Beam Therapeutics Inc   0.11 $ 156.035  Millions$ 1,414.853  Millions
Surrozen Inc   0.11 $ 11.511  Millions$ 107.272  Millions
C4 Therapeutics Inc   0.11 $ 35.039  Millions$ 328.207  Millions
Scilex Holding Company  0.11 $ 31.608  Millions$ 297.014  Millions
Ginkgo Bioworks Holdings Inc   0.10 $ 111.863  Millions$ 1,082.996  Millions
Zymeworks Inc   0.09 $ 37.127  Millions$ 404.744  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.